Learn about a study for your loved one’s negative symptoms of schizophrenia

The INTERACT clinical study is currently recruiting participants to learn more about a new investigational medicine for persistent negative symptoms of schizophrenia. This study is looking at whether the investigational medicine is effective and safe for treating the negative symptoms of schizophrenia when it is taken with standard medications.

An option for people with persistent negative symptoms of schizophrenia

Currently, there are no Food and Drug Administration (FDA) approved medications for those living with life-altering negative symptoms of schizophrenia, such as emotional numbness, difficulty beginning and sustaining activities, and social withdrawal. You and your loved one’s participation in the INTERACT study could help.


Find a study center near you

This study is taking place at a number of study sites across the United States.